5 Top ways Navitas Life Sciences supports Insulin Biosimilars to gain First-to-Market Advantage

Diabetes is a chronic metabolic condition that is associated with elevated blood sugar levels and which can, over time, lead to serious cardiovascular...

Continue reading

Navitas Life Sciences - Driving a new normal in Regulatory Services

Rapidly changing medical affairs sector When COVID-19 in early 2020 evolved into a pandemic, it jolted the life sciences industry into action. The Pha...

Continue reading

NavitasCares: A Navitas Life Sciences Initiative to Support Employee Health and Well-being during COVID-19

Navitas Life Sciences has been quick to provide leadership to all its stakeholders, with care and health as its top priority. Safeguarding health has ...

Continue reading

8 Exciting Benefits in Using R Programming for Clinical Trial Data Analysis

Navitas Life Sciences is committed to improving clinical trial efficiency to lower cost and time to market, by investing in the latest digital tools. ...

Continue reading

4 Vital Cardiology Clinical Trial Support at Navitas Life Sciences

World Hypertension day is celebrated on May 17th, 2021, with the theme “Measure your blood pressure accurately, Control it, Live longer”...

Continue reading

4 Ways Navitas Life Sciences Supports Stellar Inhalation Studies

May is Asthma Awareness Month with May 5th having recently been celebrated as World Asthma Day, a day dedicated to raising awareness about a common ch...

Continue reading

7 Ways Navitas Life Sciences is Revolutionizing Processes and Systems with TrackWise

Navitas Life Sciences has always been poised to play a strategic role in managing clinical trials, creating immense value through technology-based sol...

Continue reading

4 Unique Ways to use our Regulatory Industry Network for access to Key insights

In the current realm of health and safety during the pandemic, officials have depended on multiple data sources for insights about the spread of COVID...

Continue reading

Decentralized Clinical Trial Support for non-COVID Clinical Trials during COVID-19 Pandemic

According to GlobalData, 67.3% trial disruption during COVID-19 pandemic in 2020 was due to suspension of patient enrollment, while 18.4% was due to d...

Continue reading

Powering intelligent Clinical Trials from Russia – Insights from our Head of Russian Operations, Natalya Volkova

Navitas Life Sciences rapidly mobilized its digital resources during the COVID-19 pandemic to ensure the smooth transition into remote work. Thus, des...

Continue reading

3 Signs of Intelligent Clinical Trials

The rise in healthcare costs spirals down into a subsequent rise in the Gross Domestic Product (GDP) of every country, forcing stakeholders to scrutin...

Continue reading

Here’s How We Define Pharmacovigilance Services and Help Build Efficient Systems

Pharmacovigilance (PV) is fundamental to the pharmaceutical industry, and it continues to grow in size, with new challenges and inclusions for safety ...

Continue reading

Key Regulatory Trends to look out for in 2021

The Global Regulatory Information Management System (RIMS) market was valued at US$ 797.2 million in 2018, with a projected yearly CAGR of nearly 14% ...

Continue reading

Here’s How Navitas Life Sciences is Future Proofing Clinical Trials

There have been significant strides in health care innovation, with a better understanding of underlying biology and identification of novel drug targ...

Continue reading

Strengthening Women’s Healthcare with a Focus on Women’s Health Issues

The COVID-19 pandemic provided a glimpse of how important health and associated healthcare is, to individuals in particular, society at large, and to ...

Continue reading

Complexity and Relevance of Data Management and Analysis explained by Paul Gilbert, Chief Operating Officer, Navitas Data Sciences

Digital innovation has been revolutionizing clinical trials and has made virtual trials possible. A critical element and driver has been the ability o...

Continue reading

Expert insights about COVID-19 Vaccines by Dr.Ayaaz Hussain Khan, Global Head, Generics

There are decisive signs to show, for the first time, that the world is taking an upper hand in the fight against COVID-19, with multiple vaccination ...

Continue reading

Insights from Our Regulatory & Pharmacovigilance Expert - A Conversation with Marty Boom

In 2020, the value of the global regulatory affairs outsourcing market size was 6.3 billion, with an expected compound annual growth rate (CAGR) of ne...

Continue reading

Future ready workforce for post COVID decentralized clinical trials

The vaccines that are being steadily rolled out across the globe have raised significant hopes of the pandemic reaching a turning point. The pandemic ...

Continue reading

Oncology Clinical Trial Trends in 2021: Key Innovations for success in onco-research

2021 is going to be the year of healthcare, and with February 4th celebrated as “World Cancer Day”, a focus on innovations in oncology c...

Continue reading

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us